← Back to patent-cliff list
Voclosporin
Tier C — Watch / tradeVoclosporin
Aurinia
Originator
2021
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Calcineurin
Brand：Luveniq, Voclera, Orelvo, Lupkynis
Indications (approved)：狼疮肾炎
Regional status
US
Approved
2021-01-22
EU
Approved
2022-09-15
China
Phase III
2013-10-21
Japan
Approved
2024-09-24
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Voclosporin?
Approved indications include: 狼疮肾炎.
When does the Voclosporin patent expire?
No public expiry year is available for Voclosporin yet; this page updates once verified.
How do I get a quote for Voclosporin intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01